Bone Biologics (BBLG) Net Cash Flow (2016 - 2017)

Historic Net Cash Flow for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to -$931700.0.

  • Bone Biologics' Net Cash Flow fell 127301.42% to -$931700.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $69904.0, marking a year-over-year increase of 11412.96%. This contributed to the annual value of $6.7 million for FY2021, which is 2774698.7% up from last year.
  • Latest data reveals that Bone Biologics reported Net Cash Flow of -$931700.0 as of Q4 2017, which was down 127301.42% from $838965.0 recorded in Q3 2017.
  • In the past 5 years, Bone Biologics' Net Cash Flow registered a high of $3.1 million during Q1 2016, and its lowest value of -$2.0 million during Q2 2016.